Cargando…
Leaflet immobility and thrombosis in transcatheter aortic valve replacement
Transcatheter aortic valve replacement (TAVR) has grown exponentially worldwide in the last decade. Due to the higher bleeding risks associated with oral anticoagulation and in patients undergoing TAVR, antiplatelet therapy is currently considered first-line antithrombotic treatment after TAVR. Rece...
Autores principales: | Ng, Arnold C T, Holmes, David R, Mack, Michael J, Delgado, Victoria, Makkar, Raj, Blanke, Philipp, Leipsic, Jonathon A, Leon, Martin B, Bax, Jeroen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186299/ https://www.ncbi.nlm.nih.gov/pubmed/32930773 http://dx.doi.org/10.1093/eurheartj/ehaa542 |
Ejemplares similares
-
Leaflet thrombosis in transcatheter aortic valve intervention: mechanisms, prevention, and treatment options
por: Koren, Ofir, et al.
Publicado: (2023) -
Subclinical Leaflets Thrombosis After Transcatheter Replacement of Bicuspid vs. Tricuspid Aortic Valve
por: Zhu, Gangjie, et al.
Publicado: (2021) -
Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study
por: Malaisrie, S. Chris, et al.
Publicado: (2022) -
Adverse Hemodynamic Conditions Associated with Mechanical Heart Valve Leaflet Immobility
por: Khalili, Fardin, et al.
Publicado: (2018) -
Risk factors and clinical effects of subclinical leaflet thrombosis after transcatheter aortic valve replacement
por: Bak, Minjung, et al.
Publicado: (2022)